144174723.jpg

144174723.jpg

A picture taken on May 11, 2012 shows a box of antiretroviral drug Truvada -- two months before the U.S. Food and Drug Administration (FDA) approved Gilead Sciences' Truvada as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse.
Credit: JOEL SAGET